Ion Exchange (India) Ltd. News and Updates

Name: Latest research reports of Ion Exchange (India) Ltd. authored by KamayaKya Wealth and published by - Trendlyne research reports.
Item: Ion Exchange (India) Ltd.
Rating: 5
Author: KamayaKya Wealth

Keep track of all breaking news on Ion Exchange (India) Ltd. from all sources in a single place.

Load latest

Ion Exchange (India) Ltd.

03 Nov 2022

525.20

-0.77%

Initiating Coverage

Buy: Ion Exchange (India) Ltd.

KamayaKya Wealth

We estimate a 21% CAGR till FY24, driven by revenue recognition in major EPC projects, growth from the Chemical division and Consumable product division. We expect IEIL to post a PAT CAGR of ~22% during FY22-24E driven by EPC efficiencies and Chemical division margin improvement.

Ion Exchange (India) Ltd. is trading below its 100 day SMA of 571.0

Ion Exchange (India) Ltd.

26 Sep 2022, 12:00AM

525.20

-0.77%

Ion Exchange Ltd. | Company Update

Not Rated: Ion Exchange (India) Ltd.

Edelweiss

All-round growth on the cards

Ion Exchange (India) Ltd. is trading below its 100 day SMA of 571.0

Ion Exchange (India) Ltd.

05 Aug 2022

525.20

-0.77%

to see Rapid results content

Ion Exchange (India) Ltd.

07 Mar 2022

525.20

-0.77%

Ion Exchange Ltd.

Buy: Ion Exchange (India) Ltd.

Hem Securities

Co. posted decent set of numbers for the quarter ended 31st Dec 2021. During the Quarter, In Engineering division there is Improvement in order book, as order received from Numaligarh Refinery Limited, Also UP Jal Nigam project has commenced in this quarter, and Management is expecting higher revenue contribution in next few quarters....

Ion Exchange (India).. has an average target of 772.00 from 1 broker.

Ion Exchange (India) Ltd.

26 Dec 2016, 12:00AM

525.20

-0.77%

We initiate coverage on Ion Exchange (India) Ltd as a BUY with a price objective of Rs 539, which represents a potential upside of 93% from the CMP of Rs 279

Buy: Ion Exchange (India) Ltd.

Ventura

Ion Exchange, despite having a tepid performance over the last few years, is up for exciting times. Execution of the Sri Lanka project is expected to take its revenue growth trajectory higher along with a hefty improvement in margins from the Engineering segment. The US FDA nod for pharma resins is a shot in the arm as it is expected to be the next lever of growth in the chemicals segment. As a result, we expect overall revenues to grow at a CAGR of 16% over FY16-19, from Rs 869.5 crores in FY16 to Rs 1,371 crores in FY19....

Ion Exchange (India).. has an average target of 772.00 from 1 broker.

Is Ion Exchange (India) Ltd. worth buying?

231 Votes:

Buy 78.79%

Sell 13.42%

Hold 7.79%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf

31.65% Fall from 52W High

Ion Exchange (India) Ltd. News and Updates

Keep track of all breaking news on Ion Exchange (India) Ltd. from all sources in a single place.